We are live on ! Find out more
HUMA icon

Humacyte
HUMA

32 hedge funds and large institutions have $77.5M invested in Humacyte in 2021 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

600% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 1

151% more capital invested

Capital invested by funds: $30.9M → $77.5M (+$46.7M)

68% more call options, than puts

Call options by funds: $6.18M | Put options by funds: $3.69M

25% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 16

14% more funds holding

Funds holding: 28 → 32 (+4)

22.26% less ownership

Funds ownership: 29.25% → 6.99% (-22%)

Holders
32
Holders Change
+4
Holders Change %
+14.29%
% of All Funds
0.56%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
20
Increased
7
Reduced
1
Closed
16
Calls
$6.18M
Puts
$3.69M
Net Calls
+$2.49M
Net Calls Change
+$2.49M

Top Buyers

1
YCMGA
York Capital Management Global Advisors
New York
+$26.2M
2
O
OrbiMed
New York
+$17.2M
3
DCP
Diameter Capital Partners
New York
+$10.9M
4
MIM
Monashee Investment Management
Massachusetts
+$8.58M
5
CH
CVI Holdings
Delaware
+$5.72M

Top Sellers

1
Tudor Investment Corp
Tudor Investment Corp
Connecticut
-$4.1M
2
UOC
UBS O'Connor
Illinois
-$3.06M
3
ACM
Altium Capital Management
New York
-$2.8M
4
CAC
Cowen and Company
New York
-$2.45M
5
AGM
Alpine Global Management
New York
-$2.14M
Name Holding Trade Value Shares
Change 		Change in
Stake
ODG
26
O'Dell Group
Ohio
$17K +$17.2K +1,500 New
SSB
27
Sandy Spring Bank
Maryland
$15K +$15.3K +1,335 New
AWM
28
Avior Wealth Management
Nebraska
$11K – – –
CG
29
Cutler Group
California
$11K +$11.4K +1,000 New
UBS Group
30
UBS Group
Switzerland
$9K +$2.71K +237 +44%
JCM
31
Jacobi Capital Management
Pennsylvania
$7K +$6.41K +560 New
HR
32
Howe & Rusling
New York
$2K – – –
Tudor Investment Corp
33
Tudor Investment Corp
Connecticut
– -$4.1M -402,795 Closed
UOC
34
UBS O'Connor
Illinois
– -$3.06M -300,000 Closed
ACM
35
Altium Capital Management
New York
– -$2.8M -275,000 Closed
CAC
36
Cowen and Company
New York
– -$2.45M -240,690 Closed
AGM
37
Alpine Global Management
New York
– -$2.14M -209,743 Closed
EP
38
Eversept Partners
New York
– -$2.09M -205,026 Closed
PSAMP
39
P. Schoenfeld Asset Management (PSAM)
New York
– -$2.04M -200,000 Closed
OPU
40
Omni Partners US
California
– -$1.96M -191,925 Closed
ACA
41
Arena Capital Advisors
California
– -$1.02M -100,000 Closed
TCM
42
Tenor Capital Management
New York
– -$1.02M -100,000 Closed
WAM
43
Wolverine Asset Management
Illinois
– -$565K -55,503 Closed
Millennium Management
44
Millennium Management
New York
– -$557K -54,705 Closed
WRBC
45
W.R. Berkley Corp
Connecticut
– -$426K -41,838 Closed
Verition Fund Management
46
Verition Fund Management
Connecticut
– -$306K -30,000 Closed
HI
47
HBK Investments
Texas
– -$255K -25,000 Closed
FM
48
Family Management
New York
– -$146K -14,324 Closed
1
2

HUMA Hedge Fund Activity: Q3 2021 in Review

32 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Humacyte (HUMA) for Q3 2021, worth a combined $77.5M — up 151% from $30.9M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new HUMA positions and 16 closed out — a net gain of 4 holders — while 7 added to existing stakes and 1 trimmed.

The largest buyer was York Capital Management Global Advisors, opening a new position worth an estimated $26.2M. The largest seller was Tudor Investment Corp, exiting entirely with an estimated $4.1M sold.

  • 32 institutional investors held Humacyte (HUMA) as of Q3 2021, up from 28 in Q2 2021.
  • Funds reported $77.5M of Humacyte stock for Q3 2021, up 151% quarter-over-quarter.
  • 20 funds opened new Humacyte positions in Q3 2021 and 16 closed out, a net change of +4 holders.
  • The largest Humacyte buyer in Q3 2021 was York Capital Management Global Advisors, an estimated $26.2M added.
  • The largest Humacyte seller in Q3 2021 was Tudor Investment Corp, an estimated $4.1M sold.

Based on aggregated 13F filings for Q3 2021.